Byung-Hwi Ahn

Senior Vice President

Heung-Sun Chang

Senior Vice President

Kyoung-Hwan Kim

Senior Vice President

Young-Kwon Ku

President

Jong-Ho Lee

Senior Vice President

Kimoon Nam

CEO

Ki-Mun Nam

CEO

Jung-In Park

Senior Vice President

Past deals in South Korea

ADEL

Series B in 2024
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.

CastingN

Series B in 2024
CastingN Co., Ltd is a South Korean company that operates an online sourcing platform designed to connect businesses with professional subcontractors. Founded in 2015 and based in Incheon, the platform evaluates various factors such as company history, performance, recruitment history, and specialty fields to find suitable matches for outsourcing needs. CastingN facilitates a range of contracting jobs, including advertising, system development, web designing, accounting, and more, by linking companies with appropriate subcontractors from its registry. Additionally, it offers programs like job-oriented content development and offline job training to enhance the efficiency of business operations through specialized outsourcing.

Habit Factory

Series C in 2023
Habit Factory is a South Korean company that specializes in application software designed to analyze users' consumption patterns and financial data. By leveraging big data analytics, the company helps individuals understand their spending habits and encourages savings. Habit Factory also offers an insurance analysis platform that allows users to search for insurance policies using their phone numbers or credit card information. This platform aims to enhance the customer experience in financial services by providing personalized insights and recommendations based on users' financial behaviors. Through its innovative solutions, Habit Factory empowers users to make informed financial decisions.

Bosalpim

Seed Round in 2022
Bosalpim is a supplier of visiting care brokerage services for the elderly. Headquartered in Gangnam-gu, Seoul.

G+FLAS Life Sciences

Series E in 2022
G+FLAS Life Sciences is an agricultural biotechnology company focused on genome editing technologies for crops and health-related applications. It develops glycoengineered plants using CRISPR-PLUS to selectively remove glycosylation-related genes and provides gene-editing delivery methods into plant protoplasts. The company also pursues development of novel seeds and gene therapy drugs based on CRISPR-Cas, and operates plant cultivation facilities to support pharmaceutical and anticancer R&D. In addition to crop improvements, G+FLAS has explored nutritionally enhanced foods, including vitamin D3-enriched tomatoes, and has pursued strategic partnerships to scale commercialization, such as collaborations with large industry players to enable broader adoption of its technology. Through its integrated approach spanning plant biotechnology and therapeutic research, G+FLAS Life Sciences aims to advance sustainable agriculture and novel drug development.

Dr.Diary

Series B in 2022
Dr.Diary is a company that specializes in developing a diabetes management application aimed at assisting users in monitoring and controlling their diabetes. Founded in 2017 and headquartered in Seoul, South Korea, the application allows users to track their blood glucose levels, record daily exercise routines, and receive reminders for medication intake. Additionally, it offers insights into how various foods affect blood sugar levels, thereby helping users make informed dietary choices. The platform includes features such as monthly health reports, daily tips for diabetes management, and communication tools that facilitate personal consultations with healthcare professionals. Through these services, Dr.Diary aims to empower individuals with diabetes to better manage their health and improve their quality of life.

NearthLab

Series C in 2022
NearthLab, Inc. is a technology-driven company based in Seoul, South Korea, specializing in the design and development of autonomous drone software and solutions. Founded by experts in aerospace engineering, the company leverages proprietary deep-learning algorithms to enhance safety inspections in the wind and renewable energy sectors. NearthLab's product portfolio includes NearthWIND Pro, an autonomous drone designed for wind turbine inspection that utilizes AI to detect cracks and damages, as well as Zoomable, a cloud-based platform for managing and analyzing inspection data. Additionally, the NearthWIND Mobile solution offers mobile-based autonomous flight control. With a strong focus on innovation, NearthLab holds over 20 patents in Korea and internationally, allowing its clients, including major global wind turbine manufacturers, to significantly reduce inspection times and improve operational efficiency.

Y-Biologics

Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a bispecific antibody platform technology known as AliCE, which maintains the structural integrity of the parental antibody, ensuring high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL, a unique library of human antibodies, which supports its research and development efforts. The company is recognized for its contributions to the global immuno-chemotherapeutic drug market and also offers contract research services, aiming to advance its position within the biotechnology sector.

SWING

Series B in 2022
Swing Co., Ltd. is a South Korean company established in 2018, specializing in the rental of electric kickboards and scooters. The company offers a personal mobility service that allows users to rent electric scooters for commuting purposes. Customers can ride the scooters and park them in designated safe areas that do not obstruct traffic. This service aims to provide a convenient and efficient transportation option for individuals seeking to navigate urban environments using electric scooters, e-bikes, and e-mopeds.

Law&Company

Series C in 2022
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.

Dealicious

Series C in 2022
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.

Fount

Series C in 2021
Fount Inc. is an asset management Robo-Advisor company that was founded in 2015 and is headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its investing algorithm, which leverages Big Data technology and advanced computer algorithms. Fount's Robo-Advisor engine, Bluewhale, determines the optimal combination of assets by integrating financial engineering technology with asset allocation theories. The company's approach emphasizes passive investing, aiming to align investment strategies with clients' goals and risk tolerances over various time horizons. By utilizing AI technology, Fount enables clients to effectively monitor financial markets and adjust their asset allocations in response to market changes.

QANDA(Mathpresso)

Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

CLASSUM

Series A in 2021
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.

Lemonex

Series C in 2021
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, that focuses on developing and commercializing innovative solutions for cancer treatment and other intractable diseases. Founded in 2013, the company specializes in cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex is known for its drug delivery technology, including DegradaBALL, which facilitates the internalization of drug candidates into cultured cells and lesions. Additionally, it has developed PANGO, a drug screening technology that enables rapid evaluation of antiviral drugs from a library of candidates. With a commitment to advancing biotherapeutics, Lemonex aims to enhance the efficacy and precision of drug delivery in clinical settings.

Bertis

Venture Round in 2020
Bertis Inc. is a proteomics-based molecular diagnostics company founded in 2014 and headquartered in Seongnam, South Korea. The company specializes in the development and commercialization of cancer-related biomarkers aimed at early disease detection. Its flagship product, Mastocheck, provides a screening method for diagnosing stage 1 breast cancer. Additionally, Bertis is engaged in research to create biomarkers for the early diagnosis of various carcinomas and to develop new therapeutic markers and co-markers. The company employs advanced bio-big data analysis technologies to discover and develop markers that integrate proteomics, genomics, and bioinformatics, enhancing the diagnostic capabilities for cancer and cardiac diseases.

Huinno

Series B in 2020
Huinno, Inc. is a healthcare technology company established in 2014 and headquartered in Boston, Massachusetts, with additional offices in New York and Seoul. The company specializes in developing advanced healthcare devices designed to monitor vital health data, including blood pressure, heart rate, electrocardiograms (ECG), and blood oxygen saturation levels. Utilizing proprietary wearable devices along with AI-based analytics, Huinno aims to transform the management of chronic cardiac diseases by providing continuous, real-time health monitoring with clinical-grade accuracy. Their platform includes an application and a cloud-based ecosystem that facilitates longitudinal trend analysis of patients' health metrics, medication compliance, and lifestyle habits. By offering healthcare providers a robust remote patient monitoring solution, Huinno enhances chronic disease prevention and reduces hospital readmission rates, ultimately supporting clinicians in making informed medical decisions.

Shaperon

Series C in 2020
Shaperon Inc. is a South Korean biotechnology company established in 2008, specializing in the research and development of immunological cells and innovative therapeutics. The company focuses on creating inflammasome inhibitors and nanobody therapeutics designed to address various chronic inflammatory diseases, such as atopic dermatitis, systemic inflammatory response syndrome, and neuroinflammatory disorders. Shaperon offers a range of drug candidates, including a gel-type formulation for treating atopic dermatitis and other inflammatory conditions. By developing immunotherapeutic products and single-domain neutralizing antibodies, Shaperon aims to enhance patient quality of life through effective treatment options for chronic inflammation and related health issues.

Bagelcode

Series D in 2020
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.

Trost

Series A in 2020
Trost Company, established in 2016 and headquartered in Seoul, South Korea, specializes in mental healthcare services. The company offers an array of online counseling options, including an employee assistance program (EAP) designed to support organizations in promoting mental well-being among employees. Utilizing a mobile application named TROST, the company connects users with qualified counselors who provide diagnosis and treatment through virtual consultations. Additionally, Trost offers various self-analysis tests, covering areas such as psychological health, personality assessment, depression, self-esteem, and job-related stress. Through its services, Trost aims to enhance access to mental health resources and foster psychological well-being.

CLASSUM

Venture Round in 2019
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.

Raonsecure

Venture Round in 2019
Raonsecure Co., Ltd. is an ICT security software company based in Seoul, South Korea, specializing in security solutions for financial institutions, government entities, and enterprises. Founded in 1998 and originally known as Lumensoft Ltd., the company rebranded in October 2012. Raonsecure offers a range of products, including TouchEn OnePass, a biometric authentication solution that facilitates secure payments, mobile banking, and access to various online services. The company also engages in ICT security consulting and holds multiple patents in the integrated security and IoT sectors. Raonsecure is committed to advancing future-oriented technologies and products that enhance integrated authentication through innovative methods, including human and device authentication and FIDO-based solutions.

Huinno

Series A in 2019
Huinno, Inc. is a healthcare technology company established in 2014 and headquartered in Boston, Massachusetts, with additional offices in New York and Seoul. The company specializes in developing advanced healthcare devices designed to monitor vital health data, including blood pressure, heart rate, electrocardiograms (ECG), and blood oxygen saturation levels. Utilizing proprietary wearable devices along with AI-based analytics, Huinno aims to transform the management of chronic cardiac diseases by providing continuous, real-time health monitoring with clinical-grade accuracy. Their platform includes an application and a cloud-based ecosystem that facilitates longitudinal trend analysis of patients' health metrics, medication compliance, and lifestyle habits. By offering healthcare providers a robust remote patient monitoring solution, Huinno enhances chronic disease prevention and reduces hospital readmission rates, ultimately supporting clinicians in making informed medical decisions.

D&D Pharmatech

Series B in 2019
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.

G+FLAS Life Sciences

Series C in 2019
G+FLAS Life Sciences is an agricultural biotechnology company focused on genome editing technologies for crops and health-related applications. It develops glycoengineered plants using CRISPR-PLUS to selectively remove glycosylation-related genes and provides gene-editing delivery methods into plant protoplasts. The company also pursues development of novel seeds and gene therapy drugs based on CRISPR-Cas, and operates plant cultivation facilities to support pharmaceutical and anticancer R&D. In addition to crop improvements, G+FLAS has explored nutritionally enhanced foods, including vitamin D3-enriched tomatoes, and has pursued strategic partnerships to scale commercialization, such as collaborations with large industry players to enable broader adoption of its technology. Through its integrated approach spanning plant biotechnology and therapeutic research, G+FLAS Life Sciences aims to advance sustainable agriculture and novel drug development.

Law&Company

Series B in 2019
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.

Orum Therapeutics

Series B in 2019
Orum Therapeutics, Inc. is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of a novel class of therapeutic antibodies through its proprietary cell-penetrating antibody platform, Oromabâ„¢. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's approach enables the intracellular delivery of active antibody therapeutics or payloads, allowing it to inhibit drug targets that are typically considered undruggable by existing small molecules or antibody treatments. The technology is adaptable, capable of targeting various cell types and intracellular proteins without the need for chemical modifications. By merging the precision of antibodies with the efficacy of protein degraders, Orum aims to facilitate the development of new medicines that can effectively treat patients with challenging health conditions.

Wadiz

Series C in 2019
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Dealicious

Series B in 2019
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.

QANDA(Mathpresso)

Series A in 2018
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Vuno

Series B in 2018
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

Wishket

Venture Round in 2018
Wishket Co., Ltd. is a South Korean company established in 2012 that operates an IT outsourcing platform connecting businesses with freelancers. The platform allows companies to post projects and find suitable freelancers for development work in a secure and cost-effective manner. Freelancers can also use Wishket to discover new projects and job opportunities. By utilizing customized profiles, Wishket facilitates the matching of corporate IT projects with the appropriate talent. The platform includes a private application feature and an escrow system to help mitigate trust issues and minimize transaction costs typically associated with outsourcing agreements, thus improving the overall efficiency of the hiring process.

Bagelcode

Series C in 2018
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.

Syntekabio

Series B in 2018
Syntekabio, Inc. is a bioinformatics company based in Daejeon, South Korea, founded in 2009. The firm specializes in genome analysis and the integration of bio data, utilizing advanced algorithms to create personal genome maps that facilitate disease prevention and the development of customized medications. Syntekabio also offers a technology for collecting and integrating decrypted whole genome data, which is instrumental in analyzing diseases, including rare conditions. Their MAHA supercomputer significantly reduces data-processing costs and enhances genome-based diagnostics. The company focuses on gene-related research and technology development, leveraging a genome big data platform and artificial intelligence for drug development and genetic analysis.

D&D Pharmatech

Series A in 2018
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.

Wadiz

Series B in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Wadiz

Series A in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Bagelcode

Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.

Vuno

Series A in 2016
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

Fount

Series A in 2016
Fount Inc. is an asset management Robo-Advisor company that was founded in 2015 and is headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its investing algorithm, which leverages Big Data technology and advanced computer algorithms. Fount's Robo-Advisor engine, Bluewhale, determines the optimal combination of assets by integrating financial engineering technology with asset allocation theories. The company's approach emphasizes passive investing, aiming to align investment strategies with clients' goals and risk tolerances over various time horizons. By utilizing AI technology, Fount enables clients to effectively monitor financial markets and adjust their asset allocations in response to market changes.

Stripes

Series B in 2015
Stripes is a Korea-based apparel company established in January 2013, specializing in the design and manufacture of men's clothing. The company offers a diverse collection that includes both trendy and everyday essentials such as t-shirts, shirts, and suits. Stripes also provides personalized styling services, allowing customers to customize their clothing for a perfect fit. The company's online platform facilitates convenient shopping, enabling consumers to purchase apparel from the comfort of their homes. In addition to individual sales, Stripes offers professional style consulting and customized group clothing options for businesses, helping male customers access quality apparel and accessories at competitive prices.

Wishket

Series A in 2015
Wishket Co., Ltd. is a South Korean company established in 2012 that operates an IT outsourcing platform connecting businesses with freelancers. The platform allows companies to post projects and find suitable freelancers for development work in a secure and cost-effective manner. Freelancers can also use Wishket to discover new projects and job opportunities. By utilizing customized profiles, Wishket facilitates the matching of corporate IT projects with the appropriate talent. The platform includes a private application feature and an escrow system to help mitigate trust issues and minimize transaction costs typically associated with outsourcing agreements, thus improving the overall efficiency of the hiring process.

NBT

Series B in 2015
NBT Partners is a Korean company established in 2012 and based in Seoul, specializing in mobile and online platform development services. The company offers a range of products, including Cache Slides, an application designed to verify information during shopping activities through a slide unlock screen. Additionally, NBT Partners has developed Baobab Class, an online platform that delivers personalized educational content tailored to users' needs. The company focuses on creating customized accumulation systems and leveraging knowledge-based technology to enhance user experiences based on their preferences.

Parking Square

Series A in 2015
Parking Square Inc provides smart mobile solutions and services for parking services in Korea. It provides solutions for real time parking services involving booking and discounts. Parking Square Inc provides an application known as Park Here, which allows users to find, locate, and book parking spaces at discounted rates. Parking Square is available as an iOS and Android app. It also enables garage owners and operators to promote and rent out their idle parking space. The company was established on May 7, 2013, based in Seoul, Korea.

Stripes

Series A in 2014
Stripes is a Korea-based apparel company established in January 2013, specializing in the design and manufacture of men's clothing. The company offers a diverse collection that includes both trendy and everyday essentials such as t-shirts, shirts, and suits. Stripes also provides personalized styling services, allowing customers to customize their clothing for a perfect fit. The company's online platform facilitates convenient shopping, enabling consumers to purchase apparel from the comfort of their homes. In addition to individual sales, Stripes offers professional style consulting and customized group clothing options for businesses, helping male customers access quality apparel and accessories at competitive prices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.